Baidu
map
ONCOIMMUNOLOGY 润色咨询

OncoImmunology

出版年份:暂无数据 年文章数:2320 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2024-07-26 xyzt 来自广东省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:大老板说这个是关系户期刊,普通人不建议投哭

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2023-02-03 ms8000001862673965 来自上海

    有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-07-05 只想毕业

    审稿速度:1.0
    偏重的研究方向:肿瘤;生信;体内外实验验证
    经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2023-04-19 ms1000000858912769 来自湖北省

    生信+实验这个杂志收吗?

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-05-05 ms4000001980332372

    这个杂志还收纯生信的文章吗

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2023-11-25 ms8000000203882372 来自黑龙江省

    偏重的研究方向:免疫
    经验分享:请问这个杂志还收纯生信吗 谢谢

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2020-03-01 147a5f5cm41(暂无昵称)

    第一篇sci接收了 开心

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-09-24 ms5000001856769052

    请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2023-03-06 3264907_6241 来自吉林省

    为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2216926, encodeId=bb3622169268f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:大老板说这个是关系户期刊,普通人不建议投哭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Fri Jul 26 11:40:13 CST 2024, time=2024-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗?我全文6500字,让我修改,但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0<br>偏重的研究方向:肿瘤;生信;体内外实验验证<br>经验分享:请问各位大神,泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向:免疫<br>经验分享:请问这个杂志还收纯生信吗 谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了 开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬,with eidior一般多久送外审啊。投稿当天就with editor了,但是已经10天没有动静了,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里,最后一步的收费,一直不能保存,导致一直不能提交!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0<br>经验分享:2022.1.07 with editor<br>2022.1.07 out for review<br>2022.1.18 reviews complete<br>2022.1.18 decision pending<br>2022.1.19 悲剧<br>这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-19 小胖子罗军

    审稿速度:1.0
    经验分享:2022.1.07 with editor
    2022.1.07 out for review
    2022.1.18 reviews complete
    2022.1.18 decision pending
    2022.1.19 悲剧
    这个杂志速度挺快的,投稿系统也不麻烦,但是投稿时候没有让提交cover letter 和推荐审稿人。

    6

    展开6条回复
共197条页码: 1/20页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map